Skip to main content

Immunopathology of the X-Linked Lymphoproliferative Syndrome

  • Conference paper
Modern Trends in Human Leukemia IV

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 26))

  • 105 Accesses

Abstract

The immunopathogenesis of 25 kindreds affecting 100 males with the X-linked lymphoprolif erative syndrome (XT P) is being studied comprehensively by our registry and laboratory group. XLP is a combined variable immune deficiency with Epstein-Barr virus (EBV) induced phenotypes of: (1) fatal infectious mononucleosis (IM), (2) chronic IM progressive to malignant lymphoma, (3) acute IM progressive to acquired agammaglobulinemia or (4) malignant lymphoma. Cytogenetic studies of peripheral blood lymphocytes from 15 surviving males and 21 carrier females reveal random karyotype errors in several kindreds. Often polyclonal Ig or selective IgM increases and lymphocytosis with plasmacytoid forms typifies the IM phenotypes. Weakly reactive EBV-specific antibodies are found and anti-EB nuclear antigen is lacking. Antibodies to EBV are paradoxically elevated in female carriers. Initially all lymphoid tissues show immunoblastic proliferation with plasma cell differentiation and focal to extensive necrosis. Thymus gland and other lymphoid organs become depleted in T cell regions and Hassall’s corpuscles may become destroyed. Multinucleated giant cells may be seen destroying the corpuscles or calcified corpuscles are found. The lymphoid infiltrates and lesions resemble graft-versus-host response in the fatal IM phenotype. Extensive necrosis in lymph nodes and deficient Ig secretion of B-cells characterize acquired agammaglobulinemia phenotypes. The malignant lymphomas span the spectrum of B cell differentiation with most being immunoblastic sarcomas. One case probably was monoclonal thus far, others are being studied. EBV DNA hybridization of tissues from 7 patients with fatal IM revealed 1 to 20 EBV genome equivalents per cell. The patients lacked appropriate EBV antibody responses. Our studies of XLP support the hypothesis that immune deficiency the EBV permits chronic and fatal lymphoproliferative diseases in XLP following EBV infections. Owing to this knowledge, rational bases for prevention by genetic counseling and by providing high titer gammaglobulin and antiviral therapy is being attempted.

This study was supported in part by a grant from the National Institutes of Health, CA 23561-02

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bausher JC, Smith RT (1973) Studies of the Epstein-Barr virus-host relationship: autochthonous and allogeneic lymphocyte stimulation by lymphoblast cell lines in mixed cell culture. Clin Immunol Immunophathol 1:270–281

    Article  CAS  Google Scholar 

  • Berard C, O’Conor GT, Thomas LB, Torloni H (1979) Histophathological definition of Burkitt’s tumor. Bull WHO 40:601–607

    Google Scholar 

  • Beverly P, Knight D (1979) News and Views: Killing comes naturally. Nature 278:119–120

    Article  Google Scholar 

  • Borzy MS, Hong R, Horowitz S et al. (1979) Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N Engl J Med 301:565–568

    Article  PubMed  CAS  Google Scholar 

  • Burkitt DP (1958) A sarcoma involving the jaws in African children. Br J Surg 46:218–223

    Article  PubMed  CAS  Google Scholar 

  • Carter RL (1975) Infectious mononucleosis: Model for self-limiting lymphoproliferation. Lancet 11:846–849

    Article  Google Scholar 

  • Carter RL, Penman HG (1969) Histopathology of infectious mononucleosis. In: Carter RL, Penman HG (eds) Infectious mononucleosis. Blackwell, Oxford Edinburgh, pp 146–161

    Google Scholar 

  • Dameshek W, Gunz F (1964) Leukemia. Grune & Stratton, New York, p 556

    Google Scholar 

  • Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet i: 702–703

    Article  Google Scholar 

  • Evans AS (1978) Infectious mononucleosis and related syndromes. J Med Sci 276:325–339

    Article  CAS  Google Scholar 

  • Hamilton JK, Paquin LA, Sullivan JL, Maurer HS, Cruzi FG, Privisor AJ, Steuber CP, Hawkins E, Yawn D, Cornet JA, Clausen K, Finkelstein JZ, Landing B, Grunnet M, Purtilo DT (1980) X-linked lymphoproliferative syndrome registry report. J Pediatr 96:669–673

    Article  PubMed  CAS  Google Scholar 

  • Hanto D, Frizzera G, Purtilo D, Sakamato K, Sullivan JL, Saemundsen AK, Klein G, Simons RL, Najarian JS (1981) Lymphoproliferative disorders in renal transplant recipients. II. A. clinical spectrum and evidence for the role of Epstein-Barr virus. Cancer Res, in press

    Google Scholar 

  • Haynes B, Schooley RT, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS (1979) Emergence of suppressor cells of Immunoglobulin synthesis during acute infectious mononucleosis. J Immunol 123:2095–2101

    PubMed  CAS  Google Scholar 

  • Heberman RB, Djeu JY, Kay HD, Ortaldo JR, Riccardi C, Bonnard GD, Holden HT, Fagnani R, Santoni A, Puccetti P (1979) Natural killer cells: characteristics and regulation of activity. Immunol Rev 44:43–70

    Article  Google Scholar 

  • Henle W, Henle G, Horwitz CA (1974) Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Human Pathol 5:551–565

    Article  CAS  Google Scholar 

  • Henle G, Lennette ET, Alspaugh MA, Henle W (1979) Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies. Clin Exp Immunol 36:415–422

    PubMed  CAS  Google Scholar 

  • Horwitz CA, Henle W, Henle G, Schmitz H (1975) Clinical evaluations of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med 58:330–338

    Article  PubMed  CAS  Google Scholar 

  • Hutt LM, Huang YT, Discomb HE, Pagano LS (1975) Emhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis. J Immunol 115:243–248

    PubMed  CAS  Google Scholar 

  • Junge U, Hoekstra J, Deinhardt F (1971) Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte cell lines. J Immunol 106:1306–1315

    PubMed  CAS  Google Scholar 

  • Klein G (1975) The Epstein-Barr virus and neoplasia N Engl J Med 293:1353–1357

    Article  PubMed  CAS  Google Scholar 

  • Klein G, Svedmyr E, Jondal M, Person PO (1976) EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer 17:21–26

    Article  PubMed  CAS  Google Scholar 

  • Klein E, Masucci MG, Masucci G, Vanky F (to be published) Natural and activated lymphocyte killers which affect tumor cells. In: Heberman R (ed) Natural cell-mediated immunity against tumors. Academic, New York

    Google Scholar 

  • Langhorne J, Feizi T (1977) Studies on heterophile antibodies of infectious mononucleosis. Clin Exp Immunol 30:354–363

    PubMed  CAS  Google Scholar 

  • McKinney AA, Cline WS (1974) Annotation: infectious mononucleosis. Br J Haematol 27:367

    Article  Google Scholar 

  • Moss DJ, Pope JH (1975) EB virus-associated nuclear antigen production and cell proliferation in adult peripheral blood leukocytes inoculated with the QIMR-WIL strain of EB virus. Int J Cancer 15:503–511

    Article  PubMed  CAS  Google Scholar 

  • Moss DJ, Rickinson AB, Pope JH (1978) Long-term T cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22:662–668

    Article  PubMed  CAS  Google Scholar 

  • Moss DJ, Rickinson AB, Pope JH (1979) Long-term T cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer 23:618–625

    Article  PubMed  CAS  Google Scholar 

  • Pagano JS, Okasinski GF (1978) Pathogenesis of infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal carcinoma: a unified scheme. In: de-Thé G, Henle W, Rapp F (eds) Oncogenesis and herpesvirus III. International Agency for Research on Cancer, Lyon, pp 687–697

    Google Scholar 

  • Papermichael M, Scheldon PJ, Holoboro EG (1974) T & B cell populations in infectious mononucleosis. Clin Exp Immunol 18:1–11

    Google Scholar 

  • Paquin LA, Maurer HS, Purtilo DT (to be published) Chromosomal abnormalities in the X-linked lymphoproliferative syndrome.

    Google Scholar 

  • Pattengale PK, Smith RW, Perlin E (1974) Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers. N Engl J Med 291:1145–1148

    Article  PubMed  CAS  Google Scholar 

  • Purtilo DT (1976a) Hypothesis: Pathogenesis and phenotypes of an X-linked lymphoproliferative syndrome. Lancet ii: 883–885

    Google Scholar 

  • Purtilo DT (1976b) Prevalence of Burkitt’s lymphoma in males. N Engl J Med 295:1484

    PubMed  CAS  Google Scholar 

  • Purtilo DT (1977) Non-Hodgkin’s lymphoma in the X-linked recessive immunodeficiency and lymphoproliferative syndromes. Semin Oncol 4:335–343

    PubMed  CAS  Google Scholar 

  • Purtilo DT (1980) Epstein-Barr virus-induced oncogenesis in immune defincient individuals. Lancet i:300–303

    Article  Google Scholar 

  • Purtilo DT (1980) Immunopathogenesis and complications of infectious mononucleosis. In: Sommers S, Rosen PP (ed) Pathology Annual 1980. Appleton-Century-Crofts pp 253–299

    Google Scholar 

  • Purtilo DT, Sullivan JL (1979) Immunological bases for superior survival of females. Am J Dis Child 133:1251–1253

    PubMed  CAS  Google Scholar 

  • Purtilo DT, Cassel C, Yang JPS (1974a) Fatal infectious mononucleosis in familial lymphohistiocytosis. N Engl J Med 291:736

    PubMed  CAS  Google Scholar 

  • Purtilo DT, Hutt L, Cassel C (1974b) X-linked recessive familial lymphohistiocytosis. Clin Res 22:705A

    Google Scholar 

  • Purtilo DT, Cassel C, Yang JPS, Stephenson SR, Harper R, Landing BH, Vawter GF (1975) X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet i: 935–941

    Article  Google Scholar 

  • Purtilo DT, DeFlorio D, Hutt LM, Bhawan J, Yang JPS, Otto R, Edwards W, Rosen FS, Vawter G (1977a) Variable phenotypic expression of X-linked recessive lymphoproliferative syndrome. N Engl J Med 297:1077–1081

    Article  PubMed  CAS  Google Scholar 

  • Purtilo DT, Yang JPH, Allegra S, DeFlorio D, Hutt L (1977b) The pathogenesis and hematopathology of the X-linked recessive lymphoproliferative syndrome. Am J Med 62:225–233

    Article  PubMed  CAS  Google Scholar 

  • Purtilo DT Bhawan J, DeNicola L et al. (1978a) Epstein-Barr virus infections in a X-linked recessive lymphoproliferative syndrome. Lancet i: 798–802

    Article  Google Scholar 

  • Purtilo DT, Hutt LM, Allegra S, Cassel C, Yang JPS (1978b) Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome. Clin Immunol Immunopathol 9:147–156

    Article  PubMed  CAS  Google Scholar 

  • Purtilo DT, Paquin LA, Gindhart T (1978c) Genetics of neoplasia: Impact of ecogenetics on oncogenesis. Am J Pathol 91:609–688

    PubMed  CAS  Google Scholar 

  • Purtilo DT, Hamilton J, Sullivan J, Paquin L, — Bhawan J, Sakamoto K (1979a) Epstein-Barr virus-induced oncogenesis in immunodeficient patients. Lab Invest 40:296

    Google Scholar 

  • Purtilo DT, Paquin LA, DeFlorio D, Virzi F, Sahkuja T (1979b) Diagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome. Semin Hematol 16:309–343

    PubMed  CAS  Google Scholar 

  • Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm A-C, Anvret M, Pritchard J, Seiff C, Pincott J, Pachman L, Rich K, Cruzi F, Cornet JA, Collins R, Barnes N, Knight J, Sandstedt B, Klein G (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with lifethreatening lymphoproliferative diseases by clinical, virological and immunopathological studies. Cancer Res, in press

    Google Scholar 

  • Purtilo DT, Sullivan JL, Paquin LA (to be published b) Biomarkers in immunodeficiency syndromes predisposing to cancer. In: Lynch H, Guirgis H (eds) Biological markers in cancer. Van Nostrand, New York

    Google Scholar 

  • Reedman BM, Klein G (1973) Cellular localizations of an Epstein-Barr vjrus (EBV)-associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int J Cancer 11:499–520

    Article  PubMed  CAS  Google Scholar 

  • Rickinson AB, Moss DJ, Pope JH (1979) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer 23:610–617

    Article  PubMed  CAS  Google Scholar 

  • Rickinson AB, Moss DJ, Pope JH, Ahlberg N (1980) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patient. Int J Caner 25:59–65

    Article  CAS  Google Scholar 

  • Royston I, Sullivan JL, Penman PO, Perlin E (1976) Cell-mediated immunity in acute infectious mononucleosis. Bibl Haematol 43:278–280

    Google Scholar 

  • Sakamoto K, Freed H, Purtilo DT (1980) Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J Immunol 125:921–925

    PubMed  CAS  Google Scholar 

  • Saksela E, Timonen T, Virtanen I, Cantell K (to be published) Regulation of human natural killer activity by interferon. In: Heberman R (ed) Natural cell-mediated immunity against tumors. Academic, New York

    Google Scholar 

  • Seemayer TA, Lapp WS, Bolande RP (1977) Thymic involution in murine graft-versushost reaction. Am J Pathol 88:119–134

    PubMed  CAS  Google Scholar 

  • Spector BD, Perry GS, Kersey JH (1978) Genetically determined immunodeficiency diseases (GDID) and malignancy: Report from the Immuno-deficiency-Cancer Registry. Clin Immunol Immunopathol 11:12–29

    Article  PubMed  CAS  Google Scholar 

  • Stebbing N (1979) Interferons and inducers in vivo. Nature 279:581–582

    Article  PubMed  CAS  Google Scholar 

  • Steel CM, Hardy DA (1970) Evidence of altered antigenicity in cultured lymphoid cells from patients with infectious mononucleosis. Lancet i: 1322–1323

    Article  Google Scholar 

  • Sullivan JL, Byron K, Brewster F, Purtillo DT (1980) Deficient natural killer (NK) cell activity in patients with the x-linked lymphoproliferative syndrome. Science 210:543–545

    Article  PubMed  CAS  Google Scholar 

  • Sutton RNP, Emond TD, Thomas DB, Doniach D (1974) The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol 17:427–436

    PubMed  CAS  Google Scholar 

  • Svedmyr E, Jondal M (1975) Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci USA 72:1622–1626

    Article  PubMed  CAS  Google Scholar 

  • Thomas DB (1972) Antibodies to membrane antigens common to thymocytes and a subpopulation of lymphocytes in infectious mononucleosis sera. Lancet i: 399–403

    Article  Google Scholar 

  • Thorley-Lawson DA (1980) The suppression of Epstein-Barr virus infection in vitro occurs after infection, but before transformation of the cell. J Immunol 124:745–751

    PubMed  CAS  Google Scholar 

  • Thorley-Lawson DA, Chess L, Strominger JL (1978) Suppression of in vitro Epstein-Barr virus antigens: a new role for adult T lymphocytes. J Exp Med 146:495–508

    Article  Google Scholar 

  • Tosato G, Magrath I, Koski I, Dooley N, Blaese M (1979) Activation of suppressor T cells during Epstein-Barr virus-induced infectious mononucleosis. N Engl J Med 301:1133–1137

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Purtilo, D.T. (1981). Immunopathology of the X-Linked Lymphoproliferative Syndrome. In: Neth, R., Gallo, R.C., Graf, T., Mannweiler, K., Winkler, K. (eds) Modern Trends in Human Leukemia IV. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 26. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67984-1_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67984-1_34

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-10622-7

  • Online ISBN: 978-3-642-67984-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics